A nurse hands over a clipboard and says “just sign here.” So what is informed consent? It is an ongoing conversation about a treatment’s risks, benefits and alternatives, and the signature only records it.
Asking for that conversation is a skill. The guide on how to speak up for yourself at the doctor covers wording and approach, while this article explains what consent should contain, what to ask before surgery and what a clinical trial adds.
Consent is a conversation, not a signature
Informed consent is a dialogue between provider and patient, not just a signed form, according to a clinical research institute’s explainer. The same source describes it as an ongoing process that needs continued communication, with the discussion updated when information or goals change. A form signed at the start of a hospital stay therefore does not close the subject.
The ethics literature adds a test of quality. A Harvard bioethics journal essay on the Common Rule notes that consent is not free if it is given without understanding or on the basis of misleading information. The table below sets the most common misunderstandings against what these sources support.
| Common belief | What the evidence supports | Planning use |
|---|---|---|
| Signing the form is the consent. | Consent is a dialogue, not just a signature on a form. | Treat the form as a record. Have the discussion first, then sign. |
| Consent happens once and cannot be revisited. | Consent is ongoing and is updated when information or goals change. | Raise new worries or changed goals with the team, even after paperwork is complete. |
| Signing without fully understanding is acceptable. | Consent is not free if it is given without understanding or with misleading information. | Ask for the explanation again instead of signing to move things along. |
The table draws on the clinical research institute’s explainer and the Harvard bioethics journal essay.
What the discussion and the form should cover
Informed consent starts with the key facts about the proposed care, presented in a form a patient can weigh.
For treatment, the content breaks down into a few parts that every patient can check against their own conversation:
- The procedure itself. The sfcri explainer lists the nature of the procedure among the elements to document, together with its risks and benefits and reasonable alternatives.
- Alternatives. University of Maryland Medical System guidance says the form should list alternative choices to the procedure, if there are any, and the risks or benefits of each.
- Refusing. The same guidance includes the possible risks or benefits of refusing the treatment or procedure. Declining is a real option, so its consequences belong in the discussion.
Together these elements make up the core of shared decision-making. The clinician supplies the medical detail, and the patient supplies goals and priorities that decide which option fits.
Questions to ask before signing a surgical consent form
A surgical consent form is only as useful as the conversation behind it. UMMS guidance says the doctor advising the treatment is usually the one who leads that discussion, before the treatment is scheduled. That timing gives room to ask questions while changing course is still easy.
About the procedure and its purpose
- What exactly will be done? The nature of the procedure is a required part of the documented discussion, so a plain description should be available.
- What is it meant to achieve? Knowing the intended benefit lets you compare it with the risks.
About risks and benefits
- Which risks are most likely, and which are most serious? Consent covers risks and benefits, and asking for both kinds keeps a rare but serious risk from being buried in a list.
- What happens if complications occur? This question turns a list on a form into a practical picture of what follows.
About alternatives and declining
- What other options exist, including waiting? The form should list alternatives, if any, with their own risks and benefits.
- What are the risks and benefits of saying no? This is part of the content UMMS guidance expects on the form.
Write the answers down or take a family member to listen. A written record of the conversation also fits naturally into a personal log, and the guide to how to keep a medical journal explains that habit.
What clinical trial consent adds
Consent for research includes everything above and then adds disclosures about the study itself. These come from the Common Rule as described in the Harvard essay and from the consent elements published by Brandeis University’s human research protection office.
- Time commitment. The form should describe the total length of time for participation.
- Risks of every kind. Brandeis points out that there is no such thing as risk-free human subject research. Its guidance asks researchers to describe potential psychological, social, legal or financial risks as well as physical ones.
- Limited confidentiality. Data are kept confidential only to the extent permitted by law, so the form should not promise absolute privacy.
- Voluntary participation. The form must state that participation is voluntary and that the participant may refuse to answer questions or withdraw. The sfcri explainer adds that trial participants are free to withdraw at any time.
- Public forms. The Harvard essay notes that consent forms for higher-risk biomedical research must be publicly available, which lets a prospective participant read a trial’s form before agreeing to be approached.
A treatment form centres on your care, so the questions focus on the procedure and your alternatives. A trial form centres on the study, so the questions shift to the commitment, the data and the exit. Ask what happens to your regular care if you withdraw before enrolling.
If the form is unclear, who can consent, and changing your mind
When you do not understand the form
Stop and ask before signing. The Harvard essay describes “understandable” as a low bar under the Common Rule, yet the updated rule still places an obligation on the investigator to facilitate understanding. Consent obtained without understanding is not free consent, so asking for plain-language explanations is part of the process, not a delay to it. If the explanation still does not make sense, say so and request another conversation.
Capacity and who signs
Consent assumes the person can understand and decide. UMMS guidance notes that people younger than 18 are considered minors, and a parent or guardian signs for them. Emancipated minors are people younger than 18 who have the legal right to make their own healthcare decisions.
After you sign
Signing does not lock a decision. Consent is ongoing, and in research the participant may withdraw at any time. If your goals or the facts change before a procedure, tell the team and ask them to go over the plan again. Related protections are described in patient rights in a hospital.
Frequently asked questions
| Question | Answer |
|---|---|
| Do informed consent rules differ across the United States? | Yes. UMMS guidance says informed consent laws in the United States vary from state to state, so the exact disclosure expected can differ by location. |
| What is the Common Rule? | It is the federal policy for protecting human research subjects, codified as 45 CFR 46 and first published in 1991. The Harvard essay explains that Part 46 has four principal subparts, with Subpart A as the basic policy. |
| Where does the idea of informed consent come from? | The sfcri explainer traces it to the Nuremberg Code, which set out ten principles for medical research, including informed consent. It also notes that institutional review boards were established in the United States in 1974 under the National Research Act. |
| Is a consent form the same as consent? | No. The form documents a discussion about the procedure, its risks and benefits and reasonable alternatives. The decision depends on that discussion. |